Cholesterol and Coronary Heart Disease: A New Era

JAMA: The Journal of the American Medical Association

Volumn 256, Issue 20, 1986, Pages 2849-2858

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; ENDOCRINE SYSTEM; ETIOLOGY; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SMOKING; SURVEY;

CHOLESTEROL; CORONARY DISEASE; DIETARY CARBOHYDRATES; DIETARY FATS; EPIDEMIOLOGIC METHODS; HUMAN; HYPERCHOLESTEROLEMIA; RISK;

EID: 0023003692     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1986.03380200087027     Document Type: Article

References (50)

1. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364.
2. Yamamoto A, Sudo H, Endo A: Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis 1980;35:259-266.
3. Bilheimer DW, Grundy SM, Brown MS, et al.: Mevinolin and colestipol stimulate receptormediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci USA 1983;80:4124-4128.
4. Illingworth DR, Sexton GJ: Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia. J Clin Invest 1984;74:1972-1978.
5. Kovanen PT, Bilheimer DW, Goldstein JL, et al.: Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci USA 1981;78:1194-1198.
6. Spady DK, Bilheimer DW, Dietschy JM: Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci USA 1983;80:3499-3503.
7. Kannel WB, Castelli W, Gordon T, et al.: Serum cholesterol, lipoproteins, and risk of coronary heart disease: The Framingham Study. Ann Intern Med 1971;74:1-12.
8. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project Research Group. J Chronic Dis 1978;31:201-306.
9. Goldbourt V, Holtzman E, Neufeld HN: Total and high density lipoprotein cholesterol in the serum and risk of mortality: Evidence of a threshold effect. Br Med J 1985;290:1239-1243.
10. Stamler J, Wentworth D, Neaton J: Is the relationship between serum cholesterol and risk of death from coronary heart disease continuous and graded? JAMA 1986;256:2823-2828.
11. Solberg LA, Strong JP: Risk factors and atherosclerotic lesions: A review of autopsy studies. Arteriosclerosis 1983;3:187-198.
12. Brown MS, Goldstein JL: Lipoprotein receptors in the liver: Control signals for plasma cholesterol traffic. J Clin Invest 1983;72:743-747.
13. Strong JP, Solberg LA, Restrepo C: Atherosclerosis in persons with coronary heart disease. Lab Invest 1968;18:527-537.
14. Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham Study. Ann Intern Med 1979;90:85-91.
15. Stamler J: Public health aspects of optimal serum lipid-lipoprotein levels. Prev Med 1979; 8:733.
16. The Lipid Research Clinics Population Studies Data Book, publication 80-1527. Bethesda, Md, National Institutes of Health, 1980, vol 1.
17. Grundy SM, Vega GL, Bilheimer DW: Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age. Arteriosclerosis 1985;5:623-630.
18. Lowering blood cholesterol to prevent heart disease, CONSENSUS CONFERENCE. JAMA 1985; 253:2080-2090.
19. Goldstein JL, Brown MS: The low density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977;46:897-930.
20. Grundy SM, Vega GL: Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia. J Lipid Res 1985;26:1464-1475.
21. Vega GL, Grundy SM: In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J Clin Invest, in press.
22. Goldstein JL, Schrott HG, Hazzard WR, et al.: Hyperlipidemia in coronary heart disease: II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-1568.
23. Sniderman A, Shapiro S, Marpole D, et al.: Association of coronary arteriosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density lipoproteins). Proc Natl Acad Sci USA 1980;77:604-608.
24. Teng B, Sniderman AD, Soutar AK, et al.: Metabolic basis of hyperapobetalipoproteinemia: Turnover of apolipoprotein B in LDL and its precursors and subfractions compared to normal and familial hypercholesterolemia. J Clin Invest 1986;77:663-672.
25. Spady DK, Dietschy J: Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc Natl Acad Sci USA 1985;82:4526-4530.
26. Keys A, Anderson JT, Grande F: Serum cholesterol response to changes in the diet: II. The effect of cholesterol in the diet. Metabolism 1965; 14:759-765.
27. Hegsted DM, McGandy RB, Myers ML, et al.: Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965;17:281-295.
28. Mattson FH: Effect of dietary cholesterol on serum cholesterol in man. J Clin Nutr 1972; 25:589-594.
29. Mahley RW, Innerarity TL, Brown MS, et al.: Cholesterol ester synthesis in macrophages: Stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. J Lipid Res 1980;21:970-980.
30. Bersot TP, Innerarity TL, Pitas RE, et al.: Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. J Clin Invest 1986;77:622-630.
31. Mahley RW: Atherogenic hyperlipoproteinemia: The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin North Am 1982;66:375-402.
32. Keys A, Anderson JT, Grande F: Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. Metabolism 1965;14:776-787.
33. Mattson FH, Grundy SM: Comparison of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.
34. Grundy SM: Comparison of monounsaturated fatty acids and carbohydrates for plasma cholesterol lowering. N Engl J Med 1986;314:745-748.
35. Carroll KK, Gammel EB, Plunkett ER: Dietary fat and mammary cancer. Can Med Assoc J 1968;98:590-594.
36. Meade CJ, Merten J: The mechanism of immunoinhibition by arachidonic and linoleic acid: Effects on the lymphoid and RF system. Int Arch Allergy Appl Immunol 1976;51:2-24.
37. Phillipson BE, Rothrock DW, Connor WE, et al.: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985;312:1210-1216.
38. Egusa G, Beltz WF, Grundy SM, et al.: Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 1985;76:596-603.
39. Kesaniemi YA, Grundy SM: Increased low density lipoprotein production associated with obesity. Arteriosclerosis 1983;3:170-177.
40. Stamler JS: Does cholesterol change alter coronary artery disease risk? Epidemiological evidence. Sci Med, 1983, pp 27-45.
41. Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-1209.
42. Kushi LH, Lew RA, Stare FJ, et al.: Diet and 20-year mortality from coronary heart disease: The Ireland-Boston Diet-Heart Study. N Engl J Med 1985;312:811-818.
43. McGee DL, Reed DM, Yano K, et al.: Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Am J Epidemiol 1984;119:667-676.
44. Kahn HA, Phillips RL, Snowdon DA, et al.: Association between reported diet and all-cause mortality: Twenty-one year follow-up on 27 530 adult Seventh-Day Adventists. Am J Epidemiol 1984;119:775-787.
45. Olson RE: Mass intervention vs screening and selective intervention for the prevention of coronary heart disease. JAMA 1986;255:2204-2207.
46. Multiple Risk Factor Intervention Trial Group: Multiple Risk Factor Intervention Trial: Risk factor changes and morbidity results. JAMA 1982;248:1465-1467.
47. Weinstein MC, Coxson PG, Williams LW, et al.: Coronary heart disease morbidity, mortality, and cost for the next quarter century, abstracted. Clin Res 1986;34:386A.
48. Grundy SM, Nix D, Whelan MF, et al.: Comparison of three cholesterol-lowering diets in normolipidemic men. JAMA 1986;256:2351-2355.
49. Keys A (ed): Coronary heart disease in seven countries. Circulation 1970;41(suppl 1):1-211.
50. Grundy SM, Bilheimer D, Blackburn H, et al.: Rationale of the diet-heart statement of the American Heart Association: Report of nutrition committee. Circulation 1982;65:839A-854A.